Mednax Reports Fourth Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
MEDNAX (MD) Tops Q4 EPS by 8c; Issues 2022 EBITDA Guidance
February 17, 2022 6:08 AM ESTMEDNAX (NYSE: MD) reported Q4 EPS of $0.52, $0.08 better than the analyst estimate of $0.44. Revenue for the quarter came in at $499 million versus the consensus estimate of $483.83 million.
On a preliminary basis, Mednax anticipates that its 2022 Adjusted EBITDA, as defined above, will be at least $270... More



